Friday, 20 October 2017

What Procurement Managers say …

27 September 2017 | Features

Procurement professionals in the pharmaceuticals industry can proactively drive value-creation.

With expiring patents, proliferation of generic drugs, rising requirements for investment in R&D and marketing and huge pressure from governments and health insurance companies to reduce end-market prices, there is enormous opportunity for procurement to increase its contribution to sustainable business performance improvement.

Procurement professionals in the pharmaceuticals industry can proactively drive value-creation by: Seeking and capturing supplier innovation from the earliest stages of research and development all the way through healthcare delivery; Building collaborative, high performance partnerships with Contract Research Organizations (CROs) and other third-party providers of high-end technical and scientific services and Bringing the same measures of procurement discipline to indirect spending as they have often achieved with direct categories.

Hence Nitin Konde of BioSpectrum India spoke to procurement managers at leading pharma /healthcare companies about the current challenges they are facing and key elements to be a successful. Read their views:

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Is India becoming dependent on imports for key drug intermediates?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls